BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 2177167)

  • 21. Nelson's syndrome: incidence and prognosis.
    Kasperlik-Załuska AA; Nielubowicz J; Wisławski J; Hartwig W; Załuska J; Jeske W; Migdalska B
    Clin Endocrinol (Oxf); 1983 Dec; 19(6):693-8. PubMed ID: 6317234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early diagnosis of Nelson's syndrome.
    Kasperlik-Zaluska AA; Walecki J; Jeske W; Migdalska B; Janik J; Bonicki W; Brzeziński J; Makowska A; Brzezińska A
    J Mol Neurosci; 1996; 7(2):87-90. PubMed ID: 8873892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nelson's syndrome following partial pituitary microadenomectomy and pregnancy.
    Igoe D; Pidgeon C; Dinn J; McKenna TJ
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):429-32. PubMed ID: 1424177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of Nelson's syndrome in a patient with recurrent Cushing's disease. Analysis of secretory behavior of the pituitary tumor.
    Bitton RN; Cobbs R; Schneider BS
    Am J Med; 1988 Feb; 84(2):319-24. PubMed ID: 2841851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Long-Term Study of the Treatment of Nelson's Syndrome With Gamma Knife Radiosurgery.
    Caruso JP; Patibandla MR; Xu Z; Vance ML; Sheehan JP
    Neurosurgery; 2018 Sep; 83(3):430-436. PubMed ID: 28950324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete remission of Nelson's syndrome after 1-year treatment with cabergoline.
    Pivonello R; Faggiano A; Di Salle F; Filippella M; Lombardi G; Colao A
    J Endocrinol Invest; 1999 Dec; 22(11):860-5. PubMed ID: 10710275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors and long-term outcome in pituitary-dependent Cushing's disease.
    Sonino N; Zielezny M; Fava GA; Fallo F; Boscaro M
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2647-52. PubMed ID: 8675592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nelson's syndrome -- 46 years later: clinical experience with 37 patients.
    Kasperlik-Załuska AA; Bonicki W; Jeske W; Janik J; Zgliczyński W; Czernicki Z
    Zentralbl Neurochir; 2006 Feb; 67(1):14-20. PubMed ID: 16518746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Megavoltage pituitary irradiation in the management of Cushing's disease and Nelson's syndrome: long-term follow-up.
    Howlett TA; Plowman PN; Wass JA; Rees LH; Jones AE; Besser GM
    Clin Endocrinol (Oxf); 1989 Sep; 31(3):309-23. PubMed ID: 2559823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal menstruation and pregnancy in a patient with Nelson's syndrome.
    Burch WM
    South Med J; 1983 Oct; 76(10):1319-20. PubMed ID: 6312612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of Nelson's syndrome and residual adrenocortical function in patients of Cushing's disease after bilateral adrenalectomy.
    Misra D; Kapur MM; Gupta DK
    J Assoc Physicians India; 1994 Apr; 42(4):304-5. PubMed ID: 7860549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid response of Nelson's syndrome to pasireotide in radiotherapy-naive patient.
    He X; Spencer-Segal JL
    Clin Diabetes Endocrinol; 2020 Nov; 6(1):22. PubMed ID: 33292741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nasally located ectopic ACTH-secreting pituitary adenoma (EAPA) causing Nelson's syndrome: diagnostic challenges.
    Gurazada K; Ihuoma A; Galloway M; Dorward N; Wilhelm T; Khoo B; Bouloux PM
    Pituitary; 2014 Oct; 17(5):423-9. PubMed ID: 24065616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of Nelson's Syndrome.
    Fountas A; Karavitaki N
    Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained improvements in plasma ACTH and clinical status in a patient with Nelson's syndrome treated with pasireotide LAR, a multireceptor somatostatin analog.
    Katznelson L
    J Clin Endocrinol Metab; 2013 May; 98(5):1803-7. PubMed ID: 23539733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A correlative study between cortisol and ACTH in Cushing's disease following bilateral adrenalectomy and in Nelson's syndrome.
    Kasperlik-Załuska A; Niegowska E; Migdalska B; Jeske W; Zieliński M
    Endokrynol Pol; 1992; 43(3):314-21. PubMed ID: 1345571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rosiglitazone for prevention or adjuvant treatment of Nelson's syndrome after bilateral adrenalectomy.
    Andreassen M; Kristensen LØ
    Eur J Endocrinol; 2005 Oct; 153(4):503-5. PubMed ID: 16189170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nelson's syndrome: complete remission with cabergoline but not with bromocriptine or cyproheptadine treatment.
    Casulari LA; Naves LA; Mello PA; Pereira Neto A; Papadia C
    Horm Res; 2004; 62(6):300-5. PubMed ID: 15557761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nelson's syndrome and spontaneous pituitary tumor infarction.
    Jordan RM; Cook DM; Kendall JW; Kerber CW
    Arch Intern Med; 1979 Mar; 139(3):340-2. PubMed ID: 426579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.